What is Sotorasib: Uses, Dosage, Side Effects and More

Sotorasib is a targeted cancer medication that blocks a specific protein called KRAS G12C, which drives tumor growth in certain types of lung cancer. This oral medication represents a breakthrough in treating non-small cell lung cancer (NSCLC) that has spread to other parts of the body and carries this particular genetic mutation.

Think of sotorasib as a precision tool that targets cancer cells with laser-like accuracy. Unlike traditional chemotherapy that affects both healthy and cancerous cells, this medication specifically attacks the faulty protein that fuels tumor growth, potentially offering hope to patients who previously had limited treatment options.

What is Sotorasib Used For?

Sotorasib treats advanced non-small cell lung cancer in adults whose tumors have a specific genetic change called KRAS G12C mutation. Your doctor will order genetic testing on your tumor tissue to confirm you have this mutation before prescribing this medication.

This medication is typically prescribed when your cancer has progressed after you've already tried at least one other systemic therapy, such as chemotherapy or immunotherapy. About 13% of people with lung adenocarcinoma (a type of NSCLC) carry this KRAS G12C mutation, making sotorasib a valuable option for this specific group of patients.

The medication works best for people whose cancer has already spread beyond the original lung tumor to other parts of the body. Your oncologist will carefully evaluate your medical history, current health status, and genetic testing results to determine if sotorasib is the right choice for your treatment plan.

How Does Sotorasib Work?

Sotorasib works by permanently binding to the KRAS G12C protein, essentially turning off the signal that tells cancer cells to grow and divide. This protein normally acts like a cellular "on switch" for tumor growth, but the medication locks it in the "off" position.

The KRAS G12C mutation creates a faulty protein that continuously signals cancer cells to multiply. By blocking this specific protein, sotorasib helps slow down or stop tumor growth while allowing healthy cells to function normally since they don't rely on this mutated protein.

This medication is considered a moderately strong targeted therapy. While it's gentler than traditional chemotherapy, it's still a powerful cancer treatment that requires careful monitoring. The targeted approach means fewer side effects than broad-spectrum treatments, but you'll still need regular check-ups to ensure it's working effectively.

How Should I Take Sotorasib?

Take sotorasib exactly as your doctor prescribes, typically 960 mg (eight 120 mg tablets) once daily. Swallow the tablets whole with a full glass of water, and don't crush, chew, or break them since this can affect how the medication is absorbed.

You can take sotorasib with or without food, but try to take it at the same time each day to maintain consistent levels in your bloodstream. If you have trouble swallowing pills, talk to your healthcare team about strategies that might help, but never alter the tablets without guidance.

Store your medication at room temperature, away from heat and moisture. Keep track of your supply and contact your pharmacy well before you run out, as this medication may require special ordering and insurance approval.

How Long Should I Take Sotorasib For?

You'll typically continue taking sotorasib as long as it's controlling your cancer and you're tolerating the side effects reasonably well. Your doctor will monitor your response through regular scans and blood tests, usually every 6-8 weeks initially.

Treatment duration varies significantly from person to person. Some people may take sotorasib for several months, while others might continue for years if it remains effective. Your oncologist will regularly assess whether the medication is shrinking your tumors or preventing them from growing.

If your cancer progresses despite treatment or if you develop serious side effects, your doctor will discuss adjusting your dose or switching to a different treatment approach. Never stop taking sotorasib suddenly without consulting your healthcare team, as this could allow your cancer to grow more rapidly.

What Are the Side Effects of Sotorasib?

Most people experience some side effects with sotorasib, but many are manageable with proper medical support. The most common side effects affect your digestive system, liver function, and overall energy levels.

Here are the side effects you're most likely to experience, and remember that your healthcare team can help you manage most of these effectively:

• Diarrhea - This affects about 4 out of 5 people and can usually be controlled with anti-diarrheal medications
• Nausea and vomiting - Anti-nausea medications can significantly reduce these symptoms
• Fatigue - This may improve over time as your body adjusts to the medication
• Liver enzyme changes - Your doctor will monitor this through regular blood tests
• Decreased appetite - Working with a nutritionist can help maintain proper nutrition
• Muscle and joint pain - Usually mild and manageable with over-the-counter pain relievers

These common side effects are generally mild to moderate and often improve after the first few weeks of treatment. Your healthcare team will provide specific strategies to help you manage each symptom effectively.

Some people may experience more serious but less common side effects that require immediate medical attention. While these occur less frequently, it's important to know what to watch for:

• Severe liver problems - Watch for yellowing of skin or eyes, dark urine, or severe abdominal pain
• Serious lung inflammation - Contact your doctor immediately if you develop new or worsening cough, chest pain, or shortness of breath
• Severe skin reactions - Widespread rash, blistering, or peeling skin requires immediate medical care
• Heart rhythm changes - Irregular heartbeat, dizziness, or fainting should be evaluated promptly

Your medical team will monitor you closely for these serious side effects through regular blood tests and physical examinations. Most people can continue treatment safely with appropriate monitoring and supportive care.

Who Should Not Take Sotorasib?

Sotorasib isn't suitable for everyone, even among people with KRAS G12C-mutated lung cancer. Your doctor will carefully review your medical history and current medications to ensure this treatment is safe for you.

You should not take sotorasib if you have severe liver disease, as the medication is processed through your liver and could worsen existing liver problems. People with certain heart conditions may also need alternative treatments, depending on the specific nature of their cardiac issues.

Pregnant women should never take sotorasib, as it can cause serious harm to developing babies. If you're of childbearing age, you'll need to use effective contraception during treatment and for at least one week after your last dose. Men should also use contraception during treatment, as the medication can be present in sperm.

If you're breastfeeding, you'll need to stop before starting sotorasib and wait at least one week after your final dose before resuming. The medication can pass into breast milk and potentially harm nursing infants.

Sotorasib Brand Name

Sotorasib is sold under the brand name Lumakras in the United States. This brand name medication is manufactured by Amgen and was approved by the FDA in 2021 as the first treatment specifically targeting the KRAS G12C mutation.

You may also see sotorasib referred to by its research code name AMG 510 in some medical literature or clinical trial information. However, when you receive your prescription, it will be labeled as Lumakras with the generic name sotorasib listed as well.

Currently, there are no generic versions of sotorasib available, so Lumakras is the only form of this medication you can obtain. Your insurance company may have specific requirements for coverage, so work with your healthcare team and pharmacist to navigate any approval processes.

Sotorasib Alternatives

If sotorasib isn't right for you or stops working effectively, several alternative treatments are available for advanced NSCLC. Your oncologist will consider your specific cancer characteristics, previous treatments, and overall health when recommending alternatives.

Other targeted therapies might be options if your tumor has different genetic mutations. For example, if you have EGFR mutations, medications like osimertinib or erlotinib could be effective. People with ALK rearrangements might benefit from alectinib or brigatinib.

Immunotherapy drugs like pembrolizumab or nivolumab work by helping your immune system recognize and attack cancer cells. These medications can be particularly effective for tumors with high levels of a protein called PD-L1.

Traditional chemotherapy combinations remain important treatment options, especially when targeted therapies aren't suitable. Your doctor might recommend platinum-based chemotherapy with drugs like carboplatin and paclitaxel, often combined with immunotherapy agents.

Is Sotorasib Better Than Other KRAS Inhibitors?

Sotorasib was the first FDA-approved medication specifically targeting KRAS G12C mutations, giving it a unique position in cancer treatment. While newer KRAS inhibitors like adagrasib are now available, comparing their effectiveness requires careful consideration of individual patient factors.

Early research suggests that different KRAS inhibitors may have slightly different side effect profiles and effectiveness rates. Some people who don't respond well to sotorasib might benefit from adagrasib, and vice versa, though more research is needed to fully understand these differences.

Your oncologist will consider factors like your previous treatments, current health status, other medications you're taking, and potential drug interactions when choosing between available KRAS inhibitors. The "best" option varies significantly from person to person based on these individual circumstances.

Rather than focusing on which medication is universally "better," it's more helpful to work with your healthcare team to identify which option aligns best with your specific situation and treatment goals.